Prevalence and predictors of fatigue among people living with HIV in Norway by Langseth, Ranveig et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=caic20
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/caic20
Prevalence and predictors of fatigue among
people living with HIV in Norway
Ranveig Langseth, Rigmor C. Berg, Ole Rysstad, Tore Sørlie, Birgit Lie &
Vegard Skogen
To cite this article: Ranveig Langseth, Rigmor C. Berg, Ole Rysstad, Tore Sørlie, Birgit Lie &
Vegard Skogen (2021): Prevalence and predictors of fatigue among people living with HIV in
Norway, AIDS Care, DOI: 10.1080/09540121.2021.1934379
To link to this article:  https://doi.org/10.1080/09540121.2021.1934379
© 2021 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group
Published online: 01 Jun 2021.
Submit your article to this journal 
Article views: 383
View related articles 
View Crossmark data
Prevalence and predictors of fatigue among people living with HIV in Norway
Ranveig Langsetha,b, Rigmor C. Bergb,c, Ole Rysstadd, Tore Sørliee,f, Birgit Lieg and Vegard Skogena,f
aDepartment of Infectious Diseases, Medical clinic, University Hospital of North Norway, Tromso, Norway; bDepartment of Community
Medicine, University of Tromsø – The Arctic University of Norway, Tromso, Norway; cDivision of Health Services, Norwegian Institute of Public
Health, Oslo, Norway; dDepartment of Internal Medicine, Hospital of Southern Norway, Kristiansand, Norway; eDepartment of Mental Health
and Substance Abuse, University Hospital of North Norway, Tromso, Norway; fInstitute for Clinical Medicine, University of Tromsø – The Arctic
University of Norway, Tromso, Norway; gDepartment of Psychosomatic and Trauma, Hospital of Southern Norway, Kristiansand, Norway
ABSTRACT
Fatigue is the most commonly noted symptom among people living with human
immunodeficiency virus (PLHIV). The aim of this study was to investigate the prevalence and
predictors of fatigue among PLHIV in Norway. Two hundred and forty-four people were
recruited from two hospitals to participate in a survey, which contained seven instruments used
to investigate mental health, addiction, quality of life, and fatigue. More than a third of the
participants (38.5%) suffered from fatigue. Predictors of fatigue were the presence of mental
distress (adjusted odds ratio [AOR] 8.98, 95%CI 3.81, 21.15), multimorbidity (AOR 5.13, 95%CI
1.40, 18.73), living alone (AOR 2.99, 95%CI 1.36, 6.56), trouble sleeping (AOR 2.67, 95%CI 1.06,
6.71), and increased body pain (AOR 1.44, 95%CI 1.25, 1.67). To improve the quality of life for
many PLHIV, the continuum of HIV care must address fatigue and its predictors.
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Introduction
The introduction of highly active antiretroviral therapy
(HAART) in 1996 and the further development of com-
bined ART (cART) have greatly impacted the health of
people living with human immunodeficiency virus
(PLHIV). Consequently, the life expectancy gap
between PLHIV and the general population has nar-
rowed (Antiretroviral_Therapy_Cohort_Collaboration,
2008, 2017). However, many PLHIV experience a mul-
titude of comorbidities and associated diseases (Batte-
gay & Elzi, 2009), with fatigue as one of the most
prevalent and disabling conditions experienced (Bar-
roso et al., 2014; Perazzo et al., 2017; Wilson et al., 2016).
Fatigue is described as an overwhelming sense of
tiredness, lack of energy, inertia, or fragility that
increases with activity and reduces the person’s normal
capacities. It is a heterogeneous condition of complex
and multifactorial etiology, which is often unknown
(Afari & Buchwald, 2003; Barroso & Voss, 2013; Davis
& Walsh, 2010). The prevalence of fatigue reported in
international studies range from 33% to 88% in
PLHIV (Henderson et al., 2005; Jong et al., 2010), and
from 7% to 42% in the general population (Finsterer
& Mahjoub, 2014; Lewis & Wessely, 1992).
To the best of our knowledge, this is the first study to
examine the prevalence of fatigue and its predictors
among PLHIV in a Scandinavian country.
Materials and methods
All adult HIV-positive patients at the HIV outpatient
clinics at the Hospital of Southern Norway (SSHF)
and University Hospital of North Norway (UNN)
were eligible to participate in this cross-sectional
study. We excluded ten participants with a pre-existing
diagnosis of a severe mental disorder or cognitive
impairment (Figure 1).
The survey comprised seven validated instruments:
the Chalder Fatigue Questionnaire (CFQ), 36-Item
Short Form Health Survey (SF-36), Hopkins symptom
checklist-25 (HSCL-25), Beck’s Depression Inventory,
version 2 (BDI-II), 16-Item Post Traumatic Stress
Scale (PTSS-16), Alcohol Use Disorder Identification
Test (AUDIT), and Drug Use Disorder Identification
Test (DUDIT).
Fatigue was measured with the CFQ, a validated scale
for assessing mental and physical fatigue (Chalder et al.,
1993; Jackson, 2015). We used this definition of fatigue
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as our dependent variable in this analysis, and fatigue
was deemed chronic if the symptoms had been present
for 6 months or longer. A cut-off above 1.75 based on
the HSCL-25 indicated mental distress (Nettelbladt
et al., 1993; Winokur et al., 1984).
The study was approved by the Regional Committee
for Medical Research Ethics in Norway (ref: 2011/1925
REK Nord).
Using SPSS version 24, we applied descriptive stat-
istics to summarize the demographic and clinical
characteristics of the patients (shown as the mean ±
the standard deviation, SD) and logistic regression to
calculate odd ratios (ORs). To identify the regression
model with the best model fit, we entered all the poten-
tial explanatory variables (age, sex, education level, ori-
gin as an immigrant, men who have sex men (MSM),
employment status, cohabitation status, time since diag-
nosis, anti-viral treatment, virus-suppression treatment,
CD4+ count, viral hepatitis, anemia, comorbidities,
body pain, mental distress, trouble sleeping, and risk
of alcohol or drug abuse) as covariates and ran a back-
ward model with a 0.10% probability of stepwise
removal. Five covariates (living alone, high education
level, body pain, multimorbidity, mental distress) were
significant at a 5% level and were kept in the analysis.
The other variables were then re-entered into the analy-
sis and removed several times to check for changes in
the model. We eventually identified ten variables repre-
senting the socio-demographic, mental health, HIV, and
other health-related characteristics of this cohort.
Results
The prevalence of fatigue among the 244 participants
(Figure 1) was 38.5%, and 18% (n=44) suffered from
chronic fatigue. The fatigue intensity (mean CFQ)
increased with the duration of fatigue (data not
shown). Table 1 shows the sociodemographic character-
istics of the participants and Table 2 presents the HIV
and health-related characteristics.
Ten predictors independently contributed to the
regression model: age, sex, cohabitation status, high
education level, MSM, CD4+ count, multimorbidity,
body pain, mental distress, and trouble sleeping
(Table 3). Five predictor variables were significantly
associated with fatigue: mental distress (AOR 8.98,
95%CI 3.81, 21.15), multimorbidity (AOR 5.13, 95%CI
1.25, 21.15), living alone (AOR 2.99, 95%CI 1.36,
6.56), trouble sleeping (AOR 2.67, 95%CI 1.06, 6.71),
and body pain (AOR 1.44, 95%CI 1.25, 1.67). The
crude MSM variable was significantly associated with
fatigue (OR 2.51, 95%CI 1.17, 5.41), but became non-
significant after adjustment (AOR 1.43, 95%CI 0.38,
5.23).
Discussion
We found that the prevalence of fatigue among PLHIV
in Norway was 38.5% and 18% suffered from chronic
fatigue. This is in the lower range of previously reported
findings (Baye et al., 2020; Gebreyesus et al., 2020;
Figure 1. Flowchart of included participants.
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Henderson et al., 2005; Jong et al., 2010). Possible expla-
nations for the lower prevalence we identified are the
improved treatments available today and that all resi-
dents in Norway have access to free, high-quality health-
care services and other social support systems. Crucially,
the fatigue prevalence among PLHIV was considerably
higher than that found in the general Norwegian popu-
lation. Using the CFQ, Loge et al. found that 22% scored
four or more points and 11% had chronic fatigue (Loge
et al., 1998).
Mental distress, trouble sleeping, body pain, multi-
morbidity, and living alone were significant predictors
of fatigue. Nearly a third of the participants reported
symptoms of anxiety and depression, which mirrors
previous findings (Barroso et al., 2010; Barroso &
Voss, 2013; Baye et al., 2020; Gebreyesus et al., 2020;
Jong et al., 2010; Noh et al., 2012; Rodkjaer et al.,
2010). Thus, it seems that identifying and treating
depression are important when assessing fatigue treat-
ment strategies. Related, PLHIV have often experienced
traumatic events (Corless et al., 2013; Whetten et al.,
2008). In our study, all the participants who had
PTSD also had severe depression and fatigue, which
indicates a link between these three conditions. Similar
to findings in Jong et al.’s review (2010), we also found
that trouble sleeping was associated with fatigue. In a
one-year follow-up study, Barroso et al. (2016) demon-
strated that changes in depression correlated with
fatigue among PLHIV and that providing coping strat-
egies for depression, encouraging better sleep hygiene,
and increased physical activity led to a decrease in the
intensity of the participants’ fatigue.
Along with fatigue, Wilson et al. (2016) identified
muscle aches/joint pain and sleep difficulty as the
most prevalent and bothersome symptoms among
PLHIV. We identified a strong association between fati-
gue and the pain experienced by the patients, although
we did not assess the underlying cause of this pain.
We agree with Loades and Kagee (2017) that further
research is required to investigate the role of pain con-
cerning HIV-related fatigue.
We also found that participants diagnosed with one
chronic disease were less fatigued compared to those
with two or more diseases. This agrees with the findings
in Jong et al. (2010), Corless et al (2013) and Gebreyesus
et al. (2020), who documented a relationship between
the number of comorbidities and the severity of fatigue.
Lastly, there was a strong relationship between living
alone and fatigue. This relationship was also found in
a recent study among adult PLHIV in Ethiopia (Baye
et al., 2020), and in the general case, marriage is found
to have a protective effect on health and survival (Zhu
& Gu, 2010), which supports our finding.
Concerning implications, to improve quality of life of
PLHIV, healthcare providers should consider imple-
menting routines that identify and address symptoms
Table 1. Sociodemographic characteristics of the study sample (N=244).
Characteristics
Chalder Fatigue Scale Gender
Total Non-fatigued Fatigued Female Male
Participants, N (%) 244 150 (61.5) 94 (38.5) 114 (46.7) 130 (53.3)
Age (y), mean (SD) 43.7 (11.7) 42.8 (11.6) 45.2 (11.9) 41.7 (10.7) 45.5 (12.3)
Hospital N (%)
UNN 135 (55.3) 89 (59.3) 46 (48.9) 63 (55.3) 72 (55.3)
SSHF 109 (44.7) 61 (40.7) 48 (51.1) 51 (44.7) 58 (44.7)
Gender, N %
Female 114 (46.7) 76 (50.7) 38 (40.4)
Male 130 (53.3) 74 (49.3) 56 (59.6)
Cohabitation, N (%)
Living together 117 (48) 88 (58.7) 29 (30.9) 64 (65.1) 53 (40.8)
Living alone 127 (52.0) 62 (41.3) 65 (69.1) 50 (43.9) 77 (59.2)
Education, N (%)
Low education 142 (58.2) 94 (62.7) 48 (51.1) 80 (70.2) 62 (47.7)
High education 102 (41.8) 56 (37.5) 46 (48.9) 34 (29.8) 68 (52.3)
Work status, N* (%)
Working full time 85 (35.1) 61 (40.7) 24 (26.1) 36 (32.1) 49 (37.7)
Unemployed 28 (11.6) 17 (11.3) 11 (12.0) 16 (14.3) 12 (9.2)
Disable pensioner 28 (11.6) 10 (6.7) 18 (19.6) 11 (9.8) 17 (13.1)
Student 27 (11.2) 21 (14) 6 (6.5) 15 (13.4) 12 (9.2)
Other 74 (30.6) 41 (27.3) 33 (35.9) 34 (30.4) 40 (30.8)
Native country, N (%)
Norway 80 (32.8) 40 (26.7) 40 (42.6) 16 (14.0) 64 (49.2)
Europe 16 (6.6) 11 (7.3) 5 (5.3) 6 (5.3) 10 (7.7)
South-America 10 (4.1) 5 (3.3) 5 (5.3) 1 (0.9) 9 (6.9)
Asia 38 (15.6) 25 (16.7) 13 (13.8) 29 (25.4) 9 (6.9)
Africa 100 (41.0) 69 (46.0) 31 (33.0) 62 (54.4) 38 (29.2)
Note: Mental health and quality of life among people living with HIV in Northern and Southern Norway, 2014–2015.
SD: standard deviation; UNN: University hospital of North Norway; SSHF: Hospital of Southern Norway.
*N=242, 2 missing fatigued female cases from SSHF.
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of fatigue, depression, pain, and sleep disturbance. Bar-
roso et al. (2016) found that providing depression, sleep,
and physical activity support led to a decrease in the
intensity of the participants’ fatigue. Importantly,
depression, sleep disturbances, and fatigue have been
found to be associated with treatment failure (Huynh
et al., 2013). While we found no independent associ-
ation between fatigue and CD4 count, viral load, time
since diagnosis, we concur with Gay et al. (2011) who
list the treatment of fatigue as a strategy to improve
ART adherence. We note that there are conflicting
results regarding the relationship between fatigue and
advanced HIV disease, marked by measures such as
clinical stage, CD4 count, and ART regiment (Baye
et al., 2020; Gebreyesus et al., 2020), and encourage
further research into these associations. Similar to our
study, these are cross-sectional investigations that do
not allow for causal inferences. On the other hand, we
had high response rate, few exclusions, and multivariate
analyses, which increase the validity in our results.
Conclusions
More than a third (38.5%) of our sample of PLHIV
suffered from fatigue. This is almost two times higher
than the estimated prevalence in the general Norwegian
population. The strongest predictors of fatigue were
mental distress and multimorbidity, along with living
alone, trouble sleeping, and body pain. More research
on prevention and treatment strategies for PLHIV
suffering from fatigue is needed so that these rec-
ommendations can be implemented in everyday clinical
routines.
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Table 2. HIV and health-related characteristics of the study










Time since diagnose (y), mean (SD) 9.36 (7.39) 9.15 (6.85) 9.7 (8.22)
Transmission route, N (%)
Heterosexual 97 (39.8) 62 (41.3) 35 (37.2)
MSM 31 (12.7) 13 (8.7) 18 (19.1)
Other 9 (3.7) 5 (3.3) 4 (4.3)
Unknown 107 (43.8) 70 (46.7) 37 (39.4)
Antiretroviral therapy, N (%) 227 (93.0) 138 (92.0) 89 (94.7)
HIV RNA viral load < 50 copies/mL, N
(%)
211 (86.5) 130 (86.7) 81 (86.2)
CD4+ (×109/L), mean (SD) 0.53 (0.26) 0.54 (0.29) 0.52 (0.22)
Hopkins Symptoms Checklist-25,
mean (SD)
1.64 (.58) 1.35 (.32) 2.09 (.60)
Mental distress, N (%) 77 (31.5) 16 (10.6) 61 (64.9)
Beck’s Depression Inventory, Na (%)
Minimal depression 16 (6.6) 5 (3.3) 11 (12.0)
Mild depression 25 (10.3) 7 (4.7) 18 (19.5)
Moderate depression 15 (6.2) 4 (2.7) 11 (12.0)
Severe depression 19 (7.9) 0 (0) 19 (20.6)
Post-Traumatic Stress Disorder, Nb
(%)
15 (6.1) 0 (0) 15 (16.1)
Trouble sleeping, N (%) 63 (25.8) 16 (10.7) 47 (50.0)
Body pain, mean (SD) 2.93 (2.96) 1.69 (2.21) 4.90 (5.50)
Drug abuse risk, N (%) 18 (7.4) 5 (3.3) 13 (13.8)
Alcohol abuse risk, N (%) 35 (14.3) 18 (12.0) 17 (18.1)
Hepatitis C antibody, N 28 (11.5) 15 (10.0) 13 (13.8)
Anemia, N (%) 23 (9.4) 13 (8.7) 10 (10.6)
Comorbidity, N (%)
No comorbidity 191 (78.3) 121 (80.7) 70 (74.5)
Comorbidity 32 (13.1) 21 (14.0) 11 (11.7)
Multimorbidity 21 (8.6) 8 (5.3) 13 (13.8)
Note: Mental health and quality of life among people living with HIV in
Northern and Southern Norway, 2014–2015.
SD: standard deviation; MSM: Men who have sex with men, CD4+: T–lym-
phocyte cell bearing CD4+ receptor; Mental distress: Hopkins Symptoms
Checklist-25 > 1.75, Anemia (< 11.5 g/dl for women and < 13.0 g/dl for
men).
Na = 75 participants with HSCL-25 score > 1.75.
Nb = 243, one missing fatigued case.
Table 3. Logistic regression of factors associated with fatigue
(N = 244).
Crude Odds Ratio Adjusted Odds Ratio
OR 95% CI p AOR 95% CI P
Age 1.02 (0.99, 1.04) .120 1.01 (0.98, 1.05) .515
Male gender 1.49 (0.89, 2.51) .131 0.82 (0.35, 1.94) .654
Living alone 3.18 (1.84, 5.49) .000* 2.99 (1.36, 6.56) .006*
High education 1.58 (0.94, 2.66) .085 2.15 (0.95, 4.87) .068
MSM 2.51 (1.17, 5.41) .018* 1.43 (0.39, 5.23) .586
CD4+ (×109/L) 0.97 (0.88, 1.07) .514 0.90 (0.78, 1.04) .179
Multimorbidity 2.85 (1.13, 7.16) .026* 5.13 (1.40, 18.73) .013*
Body pain 1.54 (1.37, 1.73) .000* 1.44 (1.25, 1.67) .000*
Mental distress 15.48 (7.93, 30.24) .000* 8.98 (3.81, 21.15) .000*
Trouble sleeping 8.38 (4.34, 16.16) .000* 2.67 (1.06, 6.71) .037*
Note: Mental health and quality of life among people living with HIV in
Northern and Southern Norway, 2014–2015.
OR: crude odds ratio; AOR: adjusted odds ratio; CI: confidence interval; High
education level: ≥13 years of school; MSM: men who have sex with men;
CD4+: T–lymphocyte cell bearing CD4+ receptor; Mental distress: Hopkins
Symptoms Checklist-25 > 1.75.
AOR: all the scores in the logistic regression with 10 covariates (age, sex, liv-
ing alone, high education level, MSM, CD4+ (×109/L), multimorbidity,
body pain, mental distress, and trouble sleeping) are shown in this table.
Age: OR per year increase (scale 18–77); CD4+ (×109/L): OR per 0.10 increase
(scale 0.01–1.83); Body pain: OR per 1-unit increase (scale 0–10).
*Significant at 5% level.
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